Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers [Phase 2]
A Phase 2 trial evaluating Zenocutuzumab in patients with molecularly defined cancers, including non-small cell lung cancer with NRG1 fusion…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors [Phase 1]
Pfizer's PF-07820435 study in advanced solid tumors, including non-small-cell lung cancer and other indications, has been terminated at Phas…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating ociperlimab in combination with tislelizumab and chemotherapy in untreated metastatic non-small cell lung cancer ha…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma [Phase 1]
Phase 1 trial evaluating sequencing of stereotactic ablative body radiotherapy with pembrolizumab in metastatic non-small cell lung cancer h…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Special Drug Use-results Surveillance of Tabrecta Tablets
The document reports results from Special Drug Use surveillance of Tabrecta (capmatinib) tablets in non-small cell lung cancer, with the stu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors [Phase 1]
Phase 1a/1b study of TPST-1495 as monotherapy and in combination with pembrolizumab has completed status, spanning multiple solid tumors inc…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Robotic Lobectomy vs. Thoracoscopic Lobectomy for Early Stage Lung Cancer: RCT [NA]
A randomized trial comparing robotic lobectomy with thoracoscopic lobectomy for early-stage non-small cell lung cancer; the study status is …
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Real-World Study on Gene Profile in Patients With Advanced NSCLC Who Progressed on First-Line Osimertinib Therapy(GPS). [Phase 4]
Phase 4 real-world study assessing gene profiles in patients with advanced non-small cell lung cancer who progressed on first-line osimertin…
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: First Line Treatment in EGFR Mutation Positive Advanced NSCLC Patients With Central Nervous System (CNS) Metastases [Phase 2, Phase 3]
Clinical trial update indicating the completion of a Phase 2/3 study evaluating first-line treatment for EGFR mutation-positive advanced non…
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use [NA]
Completed clinical trial evaluating an enhanced tobacco intervention protocol versus standard treatment to reduce cigarette use in patients …
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 study comparing atezolizumab plus tiragolumab versus durvalumab in locally advanced, unresectable stage III non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Dacomitinib in Lung Cancer With Uncommon EGFR Mutations [Phase 2]
A Phase 2 clinical trial evaluating dacomitinib in metastatic non-small cell lung cancer with uncommon EGFR mutations is currently active bu…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: A Phase I/II Study of WJ13404 Monotherapy in Patients With Advanced or Mentastatic Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase I/II study of WJ13404 as monotherapy for locally advanced or metastatic non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer [Phase 1]
Phase 1 trial update of PeptiCRAd-1 reports safety signals and anti-tumor activity across multiple cancers; trial status is ACTIVE_NOT_RECRU…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung Cancer [NA]
This Clinical Trials update describes a decision-aid intervention intended to improve decision-making for patients with non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Safety and Efficacy of Lorbrena
Pfizer's clinical trial update reports safety and efficacy data for lorlatinib (Lorbrena) in non-small cell lung cancer. The study status is…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers [Phase 1]
Phase 1 trial evaluating TAK-676 in combination with pembrolizumab after radiation therapy across several cancers; the study completed and p…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: A Study of MORAb-202 in Participants With Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC) Adenocarcinoma (AC) [Phase 2]
This is a Phase 2 clinical trial update for MORAb-202 in previously treated metastatic non-small cell lung cancer with adenocarcinoma histol…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
An update on IMM-1-104's Phase 1/2a trial in advanced or metastatic solid tumors shows the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Study to Evaluate the Safety of Pembrolizumab in Participants With Unresectable or Metastatic Melanoma or Non-small Cell Lung Cancer in India (MK-3475-593/KEYNOTE-593) [Phase 4]
This Phase 4 trial evaluated the safety of pembrolizumab in patients with unresectable or metastatic melanoma or non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: A Clinica Study of Pyrotinib in Patients of Advanced Non-Small Cell Lung Cancer With HER2 Mutation [Phase 2]
Phase 2 trial of Pyrotinib in advanced non-small cell lung cancer with HER2 mutation has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies [Phase 1]
The Phase 1 study evaluating AB308 in combination with AB122 in participants with advanced malignancies has been completed.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC） [Phase 3]
Phase 3 clinical trial update for JS001sc or JS001 with chemotherapy in relapsed or metastatic non-squamous non-small cell lung cancer; the …
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor [Phase 2]
Phase 2 trial evaluating atezolizumab plus tiragolumab in patients with non-small cell lung cancer or advanced solid tumors who previously r…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]
A Phase 1/2 study of TC-510 from TCR2 Therapeutics in mesothelin-expressing cancers is active but not recruiting, spanning multiple indicati…